Pathogenesis of hereditary tumors: beyond the "two-hit'' hypothesis

被引:37
作者
Tucker, T [1 ]
Friedman, JM [1 ]
机构
[1] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada
关键词
hereditary retinoblastoma; Knudson's hypothesis; neurofibromatosis; 1; tuberous sclerosis complex;
D O I
10.1034/j.1399-0004.2002.620501.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Knudson's 'two-hit' hypothesis has provided extremely important insights into the pathogenesis of tumors in autosomal dominant tumor predisposition syndromes, but recent evidence suggests that some such tumors may occur without a 'second hit' or require more than two mutations. Inactivation of both RB1 alleles appears to be insufficient by itself to cause malignancy in the tumors that develop in patients with hereditary retinoblastoma. On the other hand, certain tumors in patients with tuberous sclerosis complex appear to develop in haploinsufficient tissues that do not have 'second hit' mutations of a tuberous sclerosis gene. The molecular pathogenesis of certain other tumors in patients with tuberous sclerosis complex or neuro. bromatosis 1 may not be fully explained by the 'two-hit' hypothesis either. Hereditary tumors, like nonhereditary tumors, may arise by a variety of molecular mechanisms, with loss of both alleles of a particular tumor suppressor gene being a frequent, but not invariably necessary or sufficient, event. Four models are presented to explain how various tumors may arise in patients with inherited tumor predisposition syndromes such as hereditary retinoblastoma, tuberous sclerosis complex or neuro. bromatosis 1. Even tumors of one particular type may develop by more than one mechanism.
引用
收藏
页码:345 / 357
页数:13
相关论文
共 90 条
[1]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[2]   Complete inactivation of the TSC2 gene leads to formation of hamartomas [J].
Au, KS ;
Hebert, AA ;
Roach, ES ;
Northrup, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) :1790-1795
[3]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]   CHARACTERIZATION OF FULL-LENGTH NEUROFIBROMIN - TUBULIN INHIBITS RAS GAP ACTIVITY [J].
BOLLAG, G ;
MCCORMICK, F ;
CLARK, R .
EMBO JOURNAL, 1993, 12 (05) :1923-1927
[5]  
Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO
[6]  
2-7
[7]   EXPRESSION OF RECESSIVE ALLELES BY CHROMOSOMAL MECHANISMS IN RETINOBLASTOMA [J].
CAVENEE, WK ;
DRYJA, TP ;
PHILLIPS, RA ;
BENEDICT, WF ;
GODBOUT, R ;
GALLIE, BL ;
MURPHREE, AL ;
STRONG, LC ;
WHITE, RL .
NATURE, 1983, 305 (5937) :779-784
[8]   Molecular genetic advances in tuberous sclerosis [J].
Cheadle, JP ;
Reeve, MP ;
Sampson, JR ;
Kwiatkowski, DJ .
HUMAN GENETICS, 2000, 107 (02) :97-114
[9]   BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE [J].
COLMAN, SD ;
WILLIAMS, CA ;
WALLACE, MR .
NATURE GENETICS, 1995, 11 (01) :90-92
[10]   New developments in the neurobiology of the tuberous sclerosis complex [J].
Crino, PB ;
Henske, EP .
NEUROLOGY, 1999, 53 (07) :1384-1390